India  

The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11

Video Credit: Bleacher Report AOL - Duration: 04:18s - Published
The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11Dr. Lee Savio Beers discusses with CNN’s Jake Tapper.

You Might Like


💡 newsR Knowledge: Other News Mentions

American Academy of Pediatrics US professional association

Most Parents Remain Concerned About Safety of COVID-19 Vaccines for Kids, Survey Finds [Video]

Most Parents Remain Concerned About Safety of COVID-19 Vaccines for Kids, Survey Finds

Most Parents Remain Concerned About , Safety of COVID-19 Vaccines for Kids, Survey Finds. The recent survey was conducted by the Kaiser Family Foundation. It found that close to three out of 10 parents will "definitely not" vaccinate their children against COVID-19. Another third of parents surveyed said they will wait to see how the rollout of the COVID-19 vaccine for U.S. kids will evolve. Only about 30 percent stated that their children ages five to 11 will be vaccinated "right away.". Analysts say the findings are in keeping with how parents have reacted in the past to guidance about new vaccines for children. Generally what we've seen throughout the years is that parents tend to be more careful with their kids than themselves, Dr. Sean O'Leary, American Academy of Pediatrics, via CNN. It's one of those things that predates the pandemic. , Dr. Sean O'Leary, American Academy of Pediatrics, via CNN. When you ask parents about their concerns, safety is almost always at the top, and they frequently say they don't have enough information, Dr. Sean O'Leary, American Academy of Pediatrics, via CNN. Vaccination rates for children ages 12 through 17 have decreased in recent weeks. According to the survey, . most parents acknowledge the dangers of contracting COVID-19 over possible dangers related to coronavirus vaccines. Still, nearly 60 percent of parents think they do not have enough information about the vaccines. The Centers for Disease Control and Prevention (CDC) has stated that complications due to COVID-19 vaccines are rare. Parental trust in the CDC has plummeted nearly 10 percent in recent months, from 66 percent in July to 57 percent in November

Credit: Wibbitz Top Stories    Duration: 01:31Published

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

2nd At-Home Rapid COVID Test Is Authorized by the FDA [Video]

2nd At-Home Rapid COVID Test Is Authorized by the FDA

2nd At-Home Rapid COVID Test , Is Authorized by the FDA. The U.S. Food and Drug Administration (FDA) announced its authorization on Dec. 28. The test was designed by Siemens Healthineers and can now be used in addition to the Roche test the FDA also recently approved. The authorization comes as test shortages have wracked the nation amid record-breaking numbers of infections. Officials with the Biden administration praised the FDA's move as in keeping with its COVID priorities. Increasing Americans' access to easy-to-use, reliable COVID tests is a top priority for the Biden Administration, , Xavier Becerra, Health and Human Services Secretary, via 'The Hill'. ... and we are using all resources at our disposal to make more tests available and ramp up supply, Xavier Becerra, Health and Human Services Secretary, via 'The Hill'. With daily infections topping 300,000 in the U.S., at-home testing has become a signature administration strategy. Adding two new authorized tests will give Americans more options for testing at home, , Xavier Becerra, Health and Human Services Secretary, via 'The Hill'. ... which helps keep people safe and provides peace of mind, Xavier Becerra, Health and Human Services Secretary, via 'The Hill'. FDA officials cautioned that the at-home test is not 100 percent accurate. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. , Jacqueline A. O’Shaughnessy, FDA Scientist, via 'The Hill'. Despite this, the tests offer reliable guidance in the context of a person's potential exposure to COVID-19. Negative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, Jacqueline A. O’Shaughnessy, FDA Scientist, via 'The Hill'. The Biden administration is expected to begin distribution of 500 million at-home tests sometime in January

Credit: Wibbitz Top Stories    Duration: 01:31Published
COVID-19 Pills May Conflict With Certain Medications, Study Finds [Video]

COVID-19 Pills May Conflict With Certain Medications, Study Finds

COVID-19 Pills May Conflict With , Certain Medications, Study Finds. NBC News reports experts are warning anti-viral pills created by Pfizer and Merck may not be safe for everyone. Recently cleared by the Food and Drug Administration to treat infections in patients 12 and older, anti-viral pills have been a cause for optimism in the fight against COVID-19. According to NBC News, experts have found that certain ingredients in the anti-viral pills may cause extreme reactions when paired with more widely-used medications. Oddly enough, many of the affected medications are widely prescribed to those with the highest risk of developing COVID-19 complications. Oddly enough, many of the affected medications are widely prescribed to those with the highest risk of developing COVID-19 complications. These medications include antidepressants, immunosuppressants and even inhalers. These medications include antidepressants, immunosuppressants and even inhalers. Some of these potential interactions are not trivial, and some pairings have to be avoided altogether. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Some of these potential interactions are not trivial, and some pairings have to be avoided altogether. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Some are probably easily managed. But some we’re going to have to be very careful about. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Some are probably easily managed. But some we’re going to have to be very careful about. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Amid concerns, experts remain excited by the potential of anti-viral pills. This could make a real difference in the pandemic by making an effective Covid treatment available to many people. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. This could make a real difference in the pandemic by making an effective Covid treatment available to many people. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News

Credit: Wibbitz Top Stories    Duration: 01:30Published
Pfizer's Antiviral COVID-19 Pill Authorized by FDA [Video]

Pfizer's Antiviral COVID-19 Pill Authorized by FDA

Pfizer's Antiviral COVID-19 Pill , Authorized by FDA. NPR reports the Food and Drug Administration has officially authorized the first COVID-19 antiviral pill. The pill, Paxlovid, was created by pharmaceutical company Pfizer. Experts say Pfizer's pill could keep those infected with COVID-19 from becoming ill enough to require hospitalization. . Experts say Pfizer's pill could keep those infected with COVID-19 from becoming ill enough to require hospitalization. . According to NPR, the pill is meant to be ingested twice a day for five days. Paxlovid will reportedly require a tandem dose of generic antiviral medicine ritonavir. Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill — a major step forward in the fight against this global pandemic. , Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, via NPR. Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill — a major step forward in the fight against this global pandemic. , Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, via NPR. Pfizer's studies suggest taking Paxlovid within three days of exhibiting symptoms could reduce the risk of death and hospitalization by 89%. Pfizer's studies suggest taking Paxlovid within three days of exhibiting symptoms could reduce the risk of death and hospitalization by 89%. NPR reports separate studies showed the pill only reduced 70% of hospitalizations. Experts say the effectiveness of Paxlovid shouldn't diminish when treating Omicron-related infections. The United States will reportedly purchase 10 million courses of Pfizer's new COVID-19 treatment. Pfizer says around 180,000 courses of treatment will be available by the end of the year

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Approves First Injectable HIV PrEP Drug [Video]

FDA Approves First Injectable HIV PrEP Drug

FDA Approves First , Injectable HIV PrEP Drug. On Dec. 20, the FDA approved a new drug called Apretude. It is used as pre-exposure prevention (PrEP) against HIV. The long-acting injectable medication is the first of its kind. Apretude is given every two months as opposed to pills like Truvada and Descovy, which are taken daily. FDA trials also found the injection to be more effective than the pills in reducing HIV infection. . FDA trials also found the injection to be more effective than the pills in reducing HIV infection. . Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent HIV that does not involve taking a daily pill, Dr. Debra Birnkrant, the director of antivirals division at the FDA’s Center for Drug Evaluation and Research, via statement. This injection, given every two months, will be critical to addressing the HIV epidemic in the U.S., including helping high-risk individuals and certain groups where adherence to daily medication has been a major challenge or not a realistic option, Dr. Debra Birnkrant, the director of antivirals division at the FDA’s Center for Drug Evaluation and Research, via statement. According to the CDC, last year, only 25% of the estimated 1.2 million people PrEP is recommended for were prescribed treatment. Advocates hope the new injectable option will increase PrEP usage and lower HIV infections

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Makes Abortion Pills Permanently Available via Mail [Video]

FDA Makes Abortion Pills Permanently Available via Mail

FDA Makes Abortion Pills , Permanently Available via Mail. On December 17, the U.S. Food and Drug Administration (FDA) permanently lifted restrictions on access to abortion pills. . On December 17, the U.S. Food and Drug Administration (FDA) permanently lifted restrictions on access to abortion pills. . 'The New York Times' reports that patients will now be able to receive the medication by mail, rather than obtaining it in person from certified health care providers. . The decision was announced as the Supreme Court weighs rolling back abortion rights or even overturning Roe v. Wade, the 1973 decision that legalized abortion nationwide. . Patients can now receive a prescription for abortion pills through a telemedicine appointment. . Earlier this year, the FDA temporarily made mifepristone, one of two drugs used to terminate a pregnancy, available by mail. . The new decision makes that ruling permanent. . According to the 'NYT,' the decision is likely to further polarize divisions between conservative and liberal states. 19 states currently ban patients from receiving abortion pills through telemedicine visits. . Other state, like New York and California, are expected to provide access for women in more restrictive states to obtain abortion medication. . It’s really significant. Telehealth abortions are much easier for both providers and patients, and even in states that want to do it, there have been limits on how available it is, Mary Ziegler, a law professor at Florida State University, via 'The New York Times'

Credit: Wibbitz Top Stories    Duration: 01:30Published

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Javid insists NHS staff are first in line for Covid tests [Video]

Javid insists NHS staff are first in line for Covid tests

Health secretary Sajid Javid insists NHS staff are being prioritised for Covid testing, despite the British Medical Association and Royal College of Nursing raising concerns over the availability of tests for frontline workers. Report by Chinnianl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:55Published
Dutch tourists flock to Belgium to escape New Year COVID lockdown at home [Video]

Dutch tourists flock to Belgium to escape New Year COVID lockdown at home

Thousands of Dutch visitors have been out and about in Antwerp shopping as well as eating and drinking in bars and cafés that are shut down in the Netherlands.

Credit: euronews (in English)    Duration: 01:13Published
'Welcome 2022!': Sydney sees in New Year with dazzling fireworks display [Video]

'Welcome 2022!': Sydney sees in New Year with dazzling fireworks display

The Australian city shrugged off a COVID surge with a spectacular Harbour Bridge display, while in New Zealand Auckland's celebration was a far more low-key affair.

Credit: euronews (in English)    Duration: 01:02Published
Covid-19 in France: 'Health' measures are more 'political or economical' in nature [Video]

Covid-19 in France: 'Health' measures are more 'political or economical' in nature

Credit: FRANCE 24 English    Duration: 03:38Published
Snow, ice close COVID test sites in Seattle-area [Video]

Snow, ice close COVID test sites in Seattle-area

Amid a COVID-19 surge, health officials closed coronavirus testing sites or reduced hours in the Seattle-area because of days of snow and freezing temperatures.

Credit: euronews (in English)    Duration: 01:00Published

Pfizer Pfizer American multinational pharmaceutical corporation

US health regulator authorizes Pfizer's Covid-19 pill as Omicron surges [Video]

US health regulator authorizes Pfizer's Covid-19 pill as Omicron surges

Credit: FRANCE 24 English    Duration: 01:50Published
Omicron positive despite 3 vaccine shots | Mumbai patient hospitalised | Oneindia News [Video]

Omicron positive despite 3 vaccine shots | Mumbai patient hospitalised | Oneindia News

A man has tested positive for the Omicron strain of the coronavirus despite having had 3 shots of the Pfizer vaccine, according to authorities in Mumbai. #Omicron #Mumbai #PfizerVaccine

Credit: Oneindia    Duration: 02:00Published
Pfizer says Covid-19 pill drastically reduces severe disease [Video]

Pfizer says Covid-19 pill drastically reduces severe disease

Credit: FRANCE 24 English    Duration: 01:27Published

Related videos from verified sources

FDA issues emergency use authorization for Pfizer vaccine in children 5 to 11 [Video]

FDA issues emergency use authorization for Pfizer vaccine in children 5 to 11

FDA issues EUA for Pfizer vaccine in kids 5 to 11

Credit: WEWS NewsChannel5     Duration: 02:55Published
FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11

CNN’s Nick Watt reports.

Credit: Bleacher Report AOL     Duration: 02:49Published
FDA Authorizes Pfizer’s COVID-19 Vaccine for Kids Ages 5 to 11 [Video]

FDA Authorizes Pfizer’s COVID-19 Vaccine for Kids Ages 5 to 11

FDA Authorizes , Pfizer’s COVID-19 Vaccine, for Kids Ages 5 to 11. On October 29, the Food and Drug Administration gave authorization for Pfizer-BioNTech's COVID-19 vaccine for children ages 5 to..

Credit: Wibbitz Top Stories     Duration: 01:30Published